Sotera Health
SHCSotera Health is a leading global provider of mission-critical sterilization, lab testing, and advisory services for the healthcare industry.
Earnings
Next report
Aug 6, 2026 (In 1 week)Valuation & ratios
Segments
Competitors
By market cap
By revenue growth
By net margin
Profile
Sotera Health is a leading global provider of mission-critical sterilization, lab testing, and advisory services for the healthcare industry. The company offers end-to-end solutions to ensure the safety of medical devices, pharmaceutical products, and food supplies across the global supply chain. Its value proposition centers on safeguarding global health by helping customers meet stringent regulatory requirements and ensuring products are safe for healthcare practitioners and patients.
A dominant global player in the highly regulated sterilization and lab testing market, characterized by high barriers to entry due to capital intensity and regulatory expertise.
Questions, answered.
- What is Sotera Health's market cap?
- Sotera Health (SHC) has a market capitalization of $4.9B and trades on NASDAQ.
- What is Sotera Health's revenue and profitability?
- Sotera Health generated $1.2B in trailing twelve-month revenue with net income of $117.8M, representing a net margin of 9.9%. Gross margin stands at 55.3%, with free cash flow of $96.8M. These figures are based on the Q1 2026 filing.
- Who are Sotera Health's competitors?
- Sotera Health's key competitors include STERIS plc, Charles River Laboratories, American Shared Hospital Services, and others. These companies compete in similar markets and product categories.
- Who does Sotera Health partner with?
- Sotera Health's notable partners include Westinghouse Electric Company, PSEG, Elekta.
- What subsidiaries does Sotera Health have?
- Sotera Health's subsidiaries include Sterigenics, Nordion, Nelson Labs, and others.
- Where is Sotera Health headquartered?
- Sotera Health is headquartered in United States of America and employs approximately 3,000 people. It has been publicly traded since 2020.
